Cell adhesion molecules and cytokines in middle ear effusions in children with or without recent acute otitis media

Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 2, 2004, Pages 242-248

  Russo, Eyal ^a,b   Smith, C Wayne ^a,b   Friedman, Ellen M ^a,b   Smith, E O'Brian ^a,b   Kaplan, Sheldon L ^a,b,c  

^a Baylor College of Medicine ^*

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; AUDIOGRAPHY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEARING LOSS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR EFFUSION; MUCOID OTITIS MEDIA; OTITIS MEDIA; PREOPERATIVE EVALUATION; SECRETORY OTITIS MEDIA; SEROUS OTITIS MEDIA; TYMPANOSTOMY TUBE;

EID: 1442335938     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2003.09.025     Document Type: Article

References (20)

1. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol 1980; 89(suppl 68):5-6.
2. Teele DW, Klein JO, Rosner B, et al. Otitis media with effusion during the first three years of live of life and the development of speech and language. Pediatrics 1984;74: 282-6.
3. Strober W, James SP. The interleukins. Pediatr Res 1988; 24:549-57.
4. Feldmann M, Londei M, Haworth C. T cells and lymphokines. Br Med Bull 1989;45:361-70.
5. Sturen ED, Essner R, Economou JS. Overview of biological response modifiers. Semin Surg Oncol 1989;5: 379-84.
6. Yellon RF, Leonard G, Marucha PT, et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991;101:165-9.
7. Maxwell KS, Fitzgerald JE, Burleson JA, et al. Interleukin-8 expression in otitis media. Laryngoscope 1994;104: 989-95.
8. Yellon RF, Leonard G, Marucha PT, et al. Demonstration of interleukin 6 in middle ear effusions. Arch Otolaryngol 1992;118:745-8.
9. Yellon RF, Doyle WJ, Whiteside TL, et al. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch Otolaryngol Head Neck Surg 1995;121: 865-9.
10. Ahn J, Huang C, Abramson A. Interleukin-1 causing bone destruction in middle ear cholesteatoma. Otolaryngol Head Neck Surg 1990;103:527-36.
11. Ishimi Y, Miyaura C, Jin C, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-303.
12. Johnson M, Leonard G, Kreutzer DL. Murine model of interleukin-8 induced otitis media. Laryngoscope 1997; 107:1405-8.
13. Himi T, Kamimura M, Kataura A, et al. Quantitative analysis of soluble cell adhesion molecules in otitis media with effusion. Acta Otolaryngol 1994;114:285-8.
14. Ohashi Y, Nakai Y, Tanaka A, et al. Soluble adhesion molecules in middle ear effusions from patients with chronic otitis media with effusion. Clin Otolaryngol 1998;23:231-4.
15. Etzioni A. Adhesion molecules-their role in health and disease. Pediatr Res 1996;39:191-8.
16. Mariscalco MM, Smith CW. Adhesion molecules and tissue injury. Curr Topics Intens Care 1996;3:102-30.
17. Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating intercellular adhesion molecule-1 antigen in malignant disease. Clin Exp Immunol 1991;85:3-8.
18. Himi T, Suzuki T, Kodama H, et al. Immunologic characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol Laryngol 1992;101:21-5.
19. Kamimura M, Himi T, Kataura A. Cell adhesion molecules of experimental otitis media in the rat. Acta Otolaryngol 1996;116:857-62.
20. Schousboe LP, Ovesen T, Eckhardt L, et al. How does endotoxin trigger inflammation in otitis media with effusion? Laryngoscope 2001;111:297-300.